Delpharm Montréal is a finished-dose manufacturer based in France. It appears in 24 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), MINSA (CR) and NCELS (KZ). Its GMP standing is certified by ANSM (FR), US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 1 September 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Quebec, United Arab Emirates | Not on file |
| Canada, Canada | 3002808099 |
| Bretigny Sur Orge, France | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 15 | None |
| MINSA (CR) | 4 | None |
| NCELS (KZ) | 2 | None |
| NPRA (MY) | 1 | None |
| DIGEMAPS (DO) | 1 | None |
| UZPHARM (UZ) | 1 | None |
| ANSM (FR) | None | 9 |
| US FDA | None | 1 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $21.2M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Delpharm Montréal comes back tiered against every other supplier able to file there.
Start for free